Terry Harvey
About Terry Harvey
Terry Harvey serves as the Vice President of SI Fusion at Nevro, a position he has held since 2023. With a background in sales and leadership roles at various medical device companies, he has a proven track record in driving product development and market entry in the spinal surgery sector.
Work at Nevro
Terry Harvey has been serving as the Vice President of SI Fusion at Nevro since 2023. Based in Redwood City, California, he is involved in overseeing the strategic direction and operational management of the SI Fusion division. His role includes driving innovation and ensuring the successful implementation of new technologies within the company.
Previous Experience
Before joining Nevro, Terry Harvey held several key positions in the medical device industry. He served as the East Coast Director of Expandable Interbody Sales at Stryker from 2012 to 2016. He then worked as Senior Vice President at Aurora Spine from 2018 to 2020. Additionally, he was Co-Chief Executive Officer at VYRSA Technologies in 2023, where he led the company through a significant acquisition by Nevro Corporation.
Education and Expertise
Terry Harvey earned a Master of Business Administration (MBA) from Kennesaw State University, focusing on Business Administration, Management, and Operations, between 2012 and 2014. He also holds a Bachelor of Science degree in Biology and Chemistry from the University of South Carolina. His educational background supports his extensive experience in the medical device sector.
Achievements in Medical Device Industry
During his tenure at VYRSA Technologies, Terry Harvey guided the company through a two-year FDA clearance process, ensuring compliance and market readiness for their products. He was instrumental in securing capital for SI Fusion research and development. Additionally, he delivered two novel 510k clearances for the first stand-alone SI Fusion device with integrated fixation while at Camber Spine.
Leadership and Innovation
Terry Harvey has demonstrated leadership in the medical device industry by coining the name 'VYRSA,' which reflects a commitment to excellence in SI Fusion. His strategic vision has been pivotal in navigating complex regulatory landscapes and driving product innovation, contributing to significant advancements in spinal surgery technologies.